4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-053487
CBO & EVP sold 39,878 shares at $32.78 ($1,307,201)
- CBO & EVP acquired 39,878 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kassberg Thomas Richard · CBO & EVP
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-23 | Exercise or conversion : show line 1 in the form 10b5-1 | +39,878 | $6.86 | $273,563 | 286,738 | D |
| 2023-10-23 | Sale : show line 2 in the form 10b5-1 | −39,878 | $32.78 | $1,307,201 | 246,860 | D |
| Open-market sales · 39,878 sh · avg $32.78 · $1,307,201 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-10-23 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −39,878 | 0 | D |
Loading xslF345X05/doc4.xml…